Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2016, Article ID 1316724, 3 pages
http://dx.doi.org/10.1155/2016/1316724
Case Report

Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation

Department of Pharmacy and Department of Surgery, Yale-New Haven Hospital, New Haven, CT 06510, USA

Received 27 January 2016; Revised 11 March 2016; Accepted 18 April 2016

Academic Editor: Thomas Grüning

Copyright © 2016 David P. Reardon and Peter S. Yoo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Benvenga, L. Bartolone, S. Squadrito, F. Lo Giudice, and F. Trimarchi, “Delayed intestinal absorption of levothyroxine,” Thyroid, vol. 5, no. 4, pp. 249–253, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Centanni, L. Gargano, G. Canettieri et al., “Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis,” The New England Journal of Medicine, vol. 354, no. 17, pp. 1787–1795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Liwanpo and J. M. Hershman, “Conditions and drugs interfering with thyroxine absorption,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 23, no. 6, pp. 781–792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Santaguida, C. Virili, S. C. D. Duca et al., “Thyroxine softgel capsule in patients with gastric-related T4 malabsorption,” Endocrine, vol. 49, no. 1, pp. 51–57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Vita, P. Fallahi, A. Antonelli, and S. Benvenga, “The administration of l-thyroxine as soft gel capsule or liquid solution,” Expert Opinion on Drug Delivery, vol. 11, no. 7, pp. 1103–1111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Pabla, F. Akhlaghi, and H. Zia, “A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 1, pp. 105–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Balla, R. M. Jhingan, and D. J. Rubin, “Rapid levothyroxine absorption testing: a case series of nonadherent patients,” International Journal of Endocrinology & Metabolism, vol. 13, no. 4, Article ID e31051, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Os, M. M. Al-Madani, A. N. Peiris, and T. K. Paul, “Gastroparesis—a novel cause of persistent thyroid stimulating hormone elevation in hypothyroidism,” The Journal of the Louisiana State Medical Society, vol. 167, no. 2, pp. 47–49, 2015. View at Google Scholar
  9. T.-G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, and J. Jonklaas, “Timing of levothyroxine administration affects serum thyrotropin concentration,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 10, pp. 3905–3912, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Centanni, “Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches,” Endocrine, vol. 43, no. 1, pp. 8–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Vita, G. Saraceno, F. Trimarchi, and S. Benvenga, “A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations,” Endocrine, vol. 43, no. 1, pp. 154–160, 2013. View at Publisher · View at Google Scholar · View at Scopus